Učitavanje...
Chimeric Antigen Receptor T cell Therapy for Non-Hodgkin Lymphoma
Non-Hodgkin lymphoma (NHL) is the most common hematologic malignancy. More than 20,000 people in United States, more than 37,000 people in Europe and more than 199,000 people worldwide die of NHL every year. Recent advances in immunotherapeutic approaches for cancer have resulted in development of n...
Spremljeno u:
| Izdano u: | Curr Res Transl Med |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5990429/ https://ncbi.nlm.nih.gov/pubmed/29655961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.retram.2018.03.005 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|